nach oben

Current Pediatrics Reports

Erschienen in:

01.06.2019 | Neonatology (C Juliano, Section Editor)

New Approaches to the Evaluation and Management of Well-Appearing Term and Late Preterm Neonates at Risk for Early-Onset Sepsis

verfasst von: Karen Gluck

Erschienen in: Current Pediatrics Reports | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We examine established guidelines for evaluating infants at risk for early-onset sepsis (EOS), as well as newer risk-based assessment strategies that may safely reduce unnecessary antibiotic exposure for well-appearing newborns.

Recent Findings

We highlight a new multivariate risk assessment tool (Neonatal Early-Onset Sepsis Calculator) that can reduce empirical antibiotic therapy, laboratory testing, maternal-infant separation, and healthcare costs, without increasing adverse events.

Summary

In the era of intrapartum antimicrobial prophylaxis for group B Streptococcus (GBS), the incidence of EOS among term and late preterm infants has decreased substantially. Established guidelines recommend laboratory evaluation and empirical antibiotics for all infants exposed to maternal chorioamnionitis, regardless of the infant’s clinical condition. Since the publication of these guidelines, newer evidence suggests that well-appearing infants can safely be managed with close clinical observation alone. The Neonatal Early-Onset Sepsis Calculator is a useful tool that quantifies an individual newborn’s EOS risk based on perinatal risk factors and clinical examination and has been shown to decrease laboratory evaluations and antibiotic use.

Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817–26. https://doi.org/10.1542/peds.2010-2217.CrossRefPubMedPubMedCentral

Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.PubMed

Polin RA, Committee on F, Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006–15. https://doi.org/10.1542/peds.2012-0541.CrossRefPubMed

Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC, Puopolo KM. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics. 2014;133(2):196–203. https://doi.org/10.1542/peds.2013-1866.CrossRefPubMedPubMedCentral

Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG. 2016;123(6):983–93. https://doi.org/10.1111/1471-0528.13601.CrossRefPubMed

Cotten CM. Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis. Clin Perinatol. 2015;42(1):195–206, x. https://doi.org/10.1016/j.clp.2014.10.007.CrossRefPubMed

Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol. 2011;173(3):310–8. https://doi.org/10.1093/aje/kwq400.CrossRefPubMed

Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13(5):440–7. https://doi.org/10.1038/embor.2012.32.CrossRefPubMedPubMedCentral

Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135(4):617–26. https://doi.org/10.1542/peds.2014-3407.CrossRefPubMed

10.

Alm B, Goksor E, Pettersson R, Mollborg P, Erdes L, Loid P, et al. Antibiotics in the first week of life is a risk factor for allergic rhinitis at school age. Pediatr Allergy Immunol. 2014;25(5):468–72. https://doi.org/10.1111/pai.12244.CrossRefPubMedPubMedCentral

11.

Mukhopadhyay S, Lieberman ES, Puopolo KM, Riley LE, Johnson LC. Effect of early-onset sepsis evaluations on in-hospital breastfeeding practices among asymptomatic term neonates. Hosp Pediatr. 2015;5(4):203–10. https://doi.org/10.1542/hpeds.2014-0126.CrossRefPubMed

12.

Hooven TA, Randis TM, Polin RA. What’s the harm? Risks and benefits of evolving rule-out sepsis practices. J Perinatol. 2018;38(6):614–22. https://doi.org/10.1038/s41372-018-0081-3.CrossRefPubMed

13.

Mukhopadhyay S, Taylor JA, Von Kohorn I, Flaherman V, Burgos AE, Phillipi CA, et al. Variation in sepsis evaluation across a national network of nurseries. Pediatrics. 2017;139(3). https://doi.org/10.1542/peds.2016-2845.

14.

•• Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Stratification of risk of early-onset sepsis in newborns >/= 34 weeks’ gestation. Pediatrics. 2014;133(1):30–6. https://doi.org/10.1542/peds.2013-1689 Original paper describing the updated iteration of the calculator that uses maternal data plus clinical findings to stratify risk of EOS. CrossRefPubMedPubMedCentral

15.

Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21–47. https://doi.org/10.1128/CMR.00031-13.CrossRefPubMedPubMedCentral

16.

Lamont RF, Sobel J, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Kim SK, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med. 2011;39(3):227–36. https://doi.org/10.1515/JPM.2011.035.CrossRefPubMedPubMedCentral

17.

Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000;105(1 Pt 1):21–6.CrossRefPubMed

18.

Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138(6). https://doi.org/10.1542/peds.2016-2013.

19.

Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937–41. https://doi.org/10.1097/INF.0b013e318223bad2.CrossRefPubMedPubMedCentral

20.

Cohen-Wolkowiez M, Moran C, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J. 2009;28(12):1052–6.CrossRefPubMedPubMedCentral

21.

Malloy MH. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. J Perinatol. 2014;34(8):611–5. https://doi.org/10.1038/jp.2014.81.CrossRefPubMed

22.

Romero R, Chaemsaithong P, Korzeniewski SJ, Kusanovic JP, Docheva N, Martinez-Varea A, et al. Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection? J Perinat Med. 2016;44(1):23–32. https://doi.org/10.1515/jpm-2015-0044.CrossRefPubMedPubMedCentral

23.

Greenberg MB, Anderson BL, Schulkin J, Norton ME, Aziz N. A first look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol. 2012;2012:628362–9. https://doi.org/10.1155/2012/628362.CrossRefPubMedPubMedCentral

24.

•• Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IA, Watterberg K, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127(3):426–36. https://doi.org/10.1097/AOG.0000000000001246 Description of findings from an expert panel convened to review the problematic terminology of chorioamnionitis and introduction of Tripe I. CrossRefPubMedPubMedCentral

25.

• Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr. 2015;166(4):1070–4. https://doi.org/10.1016/j.jpeds.2014.12.023 Commentary providing criticism of CDC and AAP EOS guidelines and rationale for new approaches. CrossRefPubMedPubMedCentral

26.

Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics. 2014;133(6):992–8. https://doi.org/10.1542/peds.2013-2927.CrossRefPubMed

27.

Jackson GL, Rawiki P, Sendelbach D, Manning MD, Engle WD. Hospital course and short-term outcomes of term and late preterm neonates following exposure to prolonged rupture of membranes and/or chorioamnionitis. Pediatr Infect Dis J. 2012;31(1):89–90. https://doi.org/10.1097/INF.0b013e31822fb15d.CrossRefPubMed

28.

Puopolo KM, Benitz WE, Zaoutis TE, Committee On F, Newborn, Committee On Infectious D. Management of neonates born at </=34 6/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6). https://doi.org/10.1542/peds.2018-2896.

29.

Cantoni L, Ronfani L, Da Riol R, Demarini S. Perinatal Study Group of the Region Friuli-Venezia G. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention’s 2010 recommendations. J Pediatr. 2013;163(2):568–73. https://doi.org/10.1016/j.jpeds.2013.01.034.CrossRefPubMed

30.

Flidel-Rimon O, Galstyan S, Juster-Reicher A, Rozin I, Shinwell ES. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr. 2012;101(12):e540–4. https://doi.org/10.1111/apa.12013.CrossRefPubMed

31.

Hashavya S, Benenson S, Ergaz-Shaltiel Z, Bar-Oz B, Averbuch D, Eventov-Friedman S. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified? Pediatr Infect Dis J. 2011;30(10):840–3. https://doi.org/10.1097/INF.0b013e3182223586.CrossRefPubMed

32.

Berardi A, Fornaciari S, Rossi C, Patianna V, Bacchi Reggiani ML, Ferrari F, et al. Safety of physical examination alone for managing well-appearing neonates >/= 35 weeks’ gestation at risk for early-onset sepsis. J Matern Fetal Neonatal Med. 2015;28(10):1123–7. https://doi.org/10.3109/14767058.2014.946499.CrossRefPubMed

33.

• Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171(4):365–71. https://doi.org/10.1001/jamapediatrics.2016.4678 The largest and only prospective study to date examining EOS calculator use. CrossRefPubMed

34.

Joshi NS, Gupta A, Allan JM, Cohen RS, Aby JL, Weldon B, et al. Clinical monitoring of well-appearing infants born to mothers with chorioamnionitis. Pediatrics. 2018;141(4). https://doi.org/10.1542/peds.2017-2056.

35.

• Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011;128(5):e1155–63. https://doi.org/10.1542/peds.2010-3464 Original paper describing the first iteration of the calculator based on maternal intrapartum risk factors. CrossRefPubMedPubMedCentral

36.

Shakib J, Buchi K, Smith E, Young PC. Management of newborns born to mothers with chorioamnionitis: is it time for a kinder, gentler approach? Acad Pediatr. 2015;15(3):340–4. https://doi.org/10.1016/j.acap.2014.11.007.CrossRefPubMed

37.

Kerste M, Corver J, Sonnevelt MC, van Brakel M, van der Linden PD, BA MB-L, et al. Application of sepsis calculator in newborns with suspected infection. J Matern Fetal Neonatal Med. 2016;29(23):3860–5. https://doi.org/10.3109/14767058.2016.1149563.CrossRefPubMed

38.

Warren S, Garcia M, Hankins C. Impact of neonatal early-onset sepsis calculator on antibiotic use within two tertiary healthcare centers. J Perinatol. 2017;37(4):394–7. https://doi.org/10.1038/jp.2016.236.CrossRefPubMed

39.

Money N, Newman J, Demissie S, Roth P, Blau J. Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis. J Perinatol. 2017;37(12):1304–9. https://doi.org/10.1038/jp.2017.137.CrossRefPubMed

40.

Carola D, Vasconcellos M, Sloane A, McElwee D, Edwards C, Greenspan J, et al. Utility of early-onset sepsis risk calculator for neonates born to mothers with chorioamnionitis. J Pediatr. 2018;195:48–52 e1. https://doi.org/10.1016/j.jpeds.2017.11.045.CrossRefPubMed

41.

Wortham JM, Hansen NI, Schrag SJ, Hale E, Van Meurs K, Sanchez PJ, et al. Chorioamnionitis and culture-confirmed, early-onset neonatal infections. Pediatrics. 2016;137(1). https://doi.org/10.1542/peds.2015-2323.

42.

Gong CL, Dasgupta-Tsinikas S, Zangwill KM, Bolaris M, Hay JW. Early onset sepsis calculator-based management of newborns exposed to maternal intrapartum fever: a cost benefit analysis. J Perinatol. 2019;39:571–80. https://doi.org/10.1038/s41372-019-0316-y.CrossRefPubMed

43.

Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics. 2010;126(5):903–9. https://doi.org/10.1542/peds.2010-0935.CrossRefPubMed

44.

Hornik CP, Benjamin DK, Becker KC, Benjamin DK Jr, Li J, Clark RH, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31(8):799–802. https://doi.org/10.1097/INF.0b013e318256905c.CrossRefPubMedPubMedCentral

45.

Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol. 2010;37(2):421–38. https://doi.org/10.1016/j.clp.2009.12.001.CrossRefPubMed

46.

Jan AI, Ramanathan R, Cayabyab RG. Chorioamnionitis and management of asymptomatic infants >/=35 weeks without empiric antibiotics. Pediatrics. 2017;140(1). https://doi.org/10.1542/peds.2016-2744.

47.

•• Puopolo KM, Benitz WE, Zaoutis TE, Committee On F, Newborn, Committee on Infectious D. Management of neonates born at >/=35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6). https://doi.org/10.1542/peds.2018-2894 Recent official guidance from the AAP regarding EOS management.

Titel: New Approaches to the Evaluation and Management of Well-Appearing Term and Late Preterm Neonates at Risk for Early-Onset Sepsis
verfasst von: Karen Gluck
Publikationsdatum: 01.06.2019
Verlag: Springer US
Erschienen in: Current Pediatrics Reports / Ausgabe 2/2019
Elektronische ISSN: 2167-4841
DOI: https://doi.org/10.1007/s40124-019-00190-9

Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA): a Systematic Review and Historical Perspective

Cardiology (W Zuckerman and E Silver, Section Editors)

Neurodevelopmental Outcomes in Children with Complex Congenital Heart Disease

Neonatology (C Juliano, Section Editor)

Modern Day Care of Patients With Single Ventricle Heart Disease: Late Complications of Fontan Palliation

Cardiology (W Zuckerman and E Silver, Section Editors)

Pulmonary Hypertension in Children with Sickle Cell Disease: a Review of the Current Literature

Cardiology (W Zuckerman and E Silver, Section Editors)

Neu im Fachgebiet Pädiatrie

Hohe Atrophierate nach Hodentorsion im Kindesalter

22.01.2025
Hodentorsion
Nachrichten

Auf längere Sicht ist die Atrophierate nach einer Hodentorsion pädiatrischer Patienten erschreckend hoch. Das hat eine Studie mit jahrelanger Nachbeobachtung ergeben. Entscheidend ist die Zeit, die bis zur Detorsion verstreicht.

Infektanfälligkeit in früher Kindheit: eine bleibende Last?

22.01.2025
Pädiatrische Infektiologie
Nachrichten

Wenn Kinder in den ersten Lebensjahren immer wieder Infekte durchmachen, lässt dies Schlüsse auf die Infektneigung in der weiteren Kindheit zu.

Adipositas als negativer Prognosefaktor bei Kindern mit Krebs

Eine kanadische Studie weist darauf hin, dass Übergewicht zum Zeitpunkt der Krebsdiagnose ein unabhängiger Risikofaktor für schlechtere Überlebenschancen bei erkrankten Kindern und Jugendlichen sein könnte. Allerdings sind nicht alle Patientinnen und Patienten gleichermaßen betroffen.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

16.01.2025
Primäre Glomerulonephritiden
Nachrichten

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

New Approaches to the Evaluation and Management of Well-Appearing Term and Late Preterm Neonates at Risk for Early-Onset Sepsis

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 2/2019

Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA): a Systematic Review and Historical Perspective

Neurodevelopmental Outcomes in Children with Complex Congenital Heart Disease

Modern Day Care of Patients With Single Ventricle Heart Disease: Late Complications of Fontan Palliation

Pulmonary Hypertension in Children with Sickle Cell Disease: a Review of the Current Literature

Neu im Fachgebiet Pädiatrie

Hohe Atrophierate nach Hodentorsion im Kindesalter

Infektanfälligkeit in früher Kindheit: eine bleibende Last?

Adipositas als negativer Prognosefaktor bei Kindern mit Krebs

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Update Pädiatrie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten